SynthesisPloS one2017

Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.

Shuo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.